<SEC-DOCUMENT>0001493152-21-019592.txt : 20210813
<SEC-HEADER>0001493152-21-019592.hdr.sgml : 20210813
<ACCEPTANCE-DATETIME>20210813081445
ACCESSION NUMBER:		0001493152-21-019592
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210813
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210813
DATE AS OF CHANGE:		20210813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		211169817

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): August 13, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>PROPHASE
LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Company as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-21617</B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23-2577138
    </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</FONT></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</FONT></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</FONT></P>
    <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>711
                                            Stewart Avenue, Suite 200</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>G</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">arden
    City, New York</FONT></B></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11530</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <B>(215) 345-0919</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any
of the following provisions (<I>see</I> General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Registered Pursuant to Section 12(b) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Each Exchange on Which Registered</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $0.0005</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRPH</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    Capital Market</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
2.02 Results of Operations and Financial Condition.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 13, 2021, ProPhase Labs, Inc. (the &ldquo;Company&rdquo;) issued a press release announcing its financial results for the quarter
ended June 30, 2021 and providing an update on the significant resurgence in COVID-19 testing and additional insights into its
previously announced acquisition of Nebula Genomics. A copy of the press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01 Regulation FD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced, the Company will conduct a conference call today, Friday, August 13, 2021 at 11:00 a.m. (Eastern Time) to discuss
its financial results for the second quarter ended June 30, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information included in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed &ldquo;filed&rdquo;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any registration
statement filed under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference
therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01 Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release dated August 13, 2021</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
    Labs, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><I>/s/ Monica Brady</I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica
    Brady</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 13, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 50.25pt; width: 156.75pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs Announces Financial Results for the Quarter Ended June 30, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Company
to hold a conference call today at 11:00AM ET</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garden City, NY &ndash; August 13th, 2021 (GLOBE NEWSWIRE) &ndash;
ProPhase Labs, Inc. <FONT STYLE="color: #1D2228; background-color: white">(NASDAQ: PRPH), a diversified biotech and genomics company,
today reported its financial and operational results for the quarter ended June 30, 2021.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
highlights for the quarter ended June 30, 2021 include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total revenue
    of $9.1 million for the quarter ended June 30, 2021, as compared to $3.6 million for the quarter ended June 30, 2020, an increase
    of approximately 153%.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss for the quarter
    ended June 30, 2021 of $1.4 million, or $(0.09) per share, as compared to net income of $70,000, or $0.01 per share, for the quarter
    ended June 30, 2020.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and marketable securities
    balance of $35.8 million and net working capital of $44.3 million at June 30, 2021 after paying $4.5 million special cash dividend.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
highlights for the quarter ended June 30, 2021 and since June 30, 2021 include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Announced the
    acquisition, through its wholly owned subsidiary ProPhase Precision Medicine, of Nebula Genomics, a privately-owned personalized
    medicine genomics company. The Company intends to integrate Nebula&rsquo;s whole genome sequencing services with the robust clinical
    diagnostic testing services offered at its already established CLIA-certified laboratories and expects to be able to offer consumers
    a more comprehensive genome mapping alternative to many of those currently available.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Announced the formation
    of two wholly owned subsidiaries, ProPhase Precision Medicine, which will focus on genomics testing technologies, and ProPhase Global
    Healthcare, which will seek to expand the Company&rsquo;s SARS-CoV2 testing into other countries and to pursue additional healthcare
    related initiatives.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintained equivalent cash
    balances from the first quarter to the second quarter even after paying a cash dividend in June 2021 of $4.5 million.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awarded
    contracts with Dutchess County, New York and Township of Oyster Bay to provide reliable COVID-19 testing to nearly 600,000 New York
    residents. ProPhase Labs expects to play a key part in their plans to continue reopening.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inclusion
    in the Russell Microcap Index as of June 28, 2021, expanding awareness of the company to a broader group of investors and further
    improving liquidity.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engaged
    CORE IR, a leading investor relations, public relations and strategic advisor firm, to assist the company in expanding market awareness
    for ProPhase and conveying the company&rsquo;s business model and growth strategies to the institutional and retail investment communities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
Karkus, ProPhase&rsquo;s Chief Executive Officer, commented, &ldquo;While we saw a decline in the incidence of COVID-19 from mid-January
through mid- June, 2021, the country is now experiencing a dramatic new wave of COVID-19, in part due to the emergence of new COVID-19
variants. In the first week of August alone, we processed more than 8,000 COVID-19 tests, which is one of the highest weekly levels of
testing that we have experienced in the past five months. We anticipate continued growth through the remainder of the year based on our
earlier municipal contract wins, and the opening of schools and other venues, many of which will require either vaccinations or regular
COVID testing. In addition, we are in the midst of building a sizable customer base of independent pharmacies that are providing consistent
and growing testing revenues.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;While
we expect to grow our COVID-19 testing revenues as a result of this new wave, our long-term focus now also includes the development of
our Precision Medicine subsidiary. We acquired Nebula, including net assets of approximately $3.7 million (which included approximately
$3.4 million in cash), for an aggregate purchase price of approximately $14.6 million, subject to post-closing adjustments. Nebula offers
whole genome testing services to consumers for approximately $300. We believe that we will be able to significantly lower the price to
consumers. This could have a significant positive impact on future testing revenues from our newly formed Precision Medicine subsidiary.
We believe that we will be able to improve on Nebula&rsquo;s net pre-tax margins of approximately 30% based on our existing infrastructure
and retail relationships.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
believe the future of medicine is in precision, personalized and tailored therapies that are based on each patient&rsquo;s individual
genetic makeup, and that we will be able to offer whole genome sequencing services at a lower cost with faster turnaround times based
on our existing infrastructure. We also believe that our relationships with approximately 40,000 food, drug and mass retail stores will
allow us to expand distribution beyond the single website-based online model Nebula has employed to date. We believe that we will be
able to improve on Nebula&rsquo;s current estimated next 12-month revenues of $9 million given our experience developing, manufacturing,
distributing, marketing, and selling other consumer healthcare products.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;In
addition to expanding our menu of available testing services with Nebula&rsquo;s genome sequencing technology, Nebula has been working
on launching a wide range of accessory tests designed to complement the whole genome sequencing product. These tests, if successfully
implemented, will be non-genetic (serum/plasma based or urine) designed to help increase the long-term value of our genome sequencing
services by providing actionable follow-up testing that may be advisable based on a customer&rsquo;s genetic results. Additionally, we
expect that many of these tests could be provided on a recurring, subscription basis, which could increase revenues. Potential new tests
include food sensitivity, heart health, cholesterol/lipids, HbA1c, inflammation, Vitamin D, heavy metals, metabolism, sleep, stress,
thyroid health, ovarian reserve, premenopause, and testosterone.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Behind
the raw numbers, the second quarter of 2021 was quite successful in a number of ways. Non-cash charges exceeded the net loss reported
for the second quarter. These charges are partially attributed to one-time stock-based compensation. Furthermore, although our expenses
increased in preparation for a new wave of COVID-19 testing that we expected during the second quarter, which did not ultimately materialize,
we believe that we are now well positioned to handle the current surge in testing going forward.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
continue to evaluate and pursue additional strategic and synergistic acquisitions. In particular, we will be looking to continue to build
ProPhase Precision Medicine as well as diversify ProPhase Diagnostics into other types of traditional CLIA laboratory testing including
pathology, blood, urine, toxicology, etc. We look forward to speaking with our investors later this morning and in future announcements.&rdquo;
concluded Mr. Karkus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quarter
Ended June 30, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended June 30, 2021, net revenue was $9.1 million compared to $3.6 million for the three months ended June 30, 2020.
The Company experienced higher net revenue for the three months ended June 30, 2021, primarily as a result of an increase of $7.5 million
related to its new diagnostic services business, which was offset by a decrease of $2.0 million in customer orders from its consumer
products business as a result of the timing and demand of third-party customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues for the three months ended June 30, 2021 were $4.7 million compared to $2.3 million for the three months ended June 30, 2020.
For the three months ended June 30, 2021 and 2020, the Company realized a gross margin of 48.9% and 35.3%, respectively. The increase
in gross margin from the prior period was principally due to increased margins generally associated with its new diagnostic services
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #333333">Total
operating expenses for the three months ended June 30, 2021 were $5.9 million compared to $1.2 million for the three months ended June
30, 2020. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The increase of $4.7 million in operating
expenses was principally related to growth in personnel expenses and professional fees associated with the Company&rsquo;s new diagnostic
services business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss from operations for the three months ended June 30, 2021 was $1.4 million, or ($0.09) per share, compared to the net income for
the three months ended June 30, 2020 of $70,000, or $0.01 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents and marketable debt securities as of June 30, 2021 was $35.8 million compared to $8.5 million at December 31, 2020.
Working capital was $44.3 million and $9.6 million as of June 30, 2021 and December 31, 2020, respectively. The increase of $27.3 million
in cash and cash equivalents and marketable debt securities balance for the six months ended June 30, 2021 was principally due to the
receipt of aggregate net proceeds of $40.6 million from the issuance of common stock and warrants in a registered direct offering and
public offering offset by (i) capital expenditures of $4.2 million, (ii) cash dividend payments of $4.5 million, (iii) issuance of a
promissory note of $1.0 million, and (iv) cash used in operations of $3.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call and Webcast Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
will host a conference call at 11:00 AM ET today, August 13, 2021, to review financial results and provide an update on corporate developments.
Following management&rsquo;s formal remarks, there will be a question-and-answer session.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
note that registered participants will receive their dial in number upon registration and will dial directly into the call without delay.
Those without internet access or unable to pre-register may dial in by calling: 1-866-777-2509 (domestic), or 1-412-317-5413 (international).
All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into ProPhase Labs call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
conference call will be broadcast live and available for replay at <U>https://services.choruscall.com/mediaframe/webcast.html?webcastid=gZ64EDfs
</U>and via the investor relations section of the Company&rsquo;s website at <U>www.ProPhaseLabs.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
webcast replay of the call will be available approximately one hour after the end of the call through November 13, 2021, at the above
links. A telephonic replay of the call will be available through August 27, 2021 and may be accessed by calling 1-877-344-7529 (domestic)
or 1-412-317-0088 (international) and using access code 10159437.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
ProPhase Labs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs (Nasdaq: PRPH) (&ldquo;ProPhase&rdquo;) is a diversified biotech and genomics company that seeks to leverage its CLIA lab services
to provide whole genome sequencing and research direct to consumers and build a genomics data base to be used for further research. The
Company continues to provide traditional CLIA molecular laboratory services, including COVID-19 testing. ProPhase Precision Medicine,
Inc., focuses on genomics testing technologies, a comprehensive method for analyzing entire genomes, including the genes and chromosomes
in DNA. The data obtained from genomic testing can help to identify inherited disorders and tendencies, help predict disease risk, help
identify expected drug response, and characterize genetic mutations, including those that drive cancer progression.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Diagnostics offers a broad array of clinical diagnostic and testing services at its CLIA certified laboratories. ProPhase Diagnostics
serves patients who may have SARS-CoV-2 (COVID-19) through both saliva and nasal swab methods. Critical to COVID testing, results are
provided in under 24 hours. ProPhase Diagnostics also offers PCR (polymerase chain reaction) testing for Influenzas A and B and RSV;
as well as antigen and antibody/immunity tests to broaden its COVID-19 testing beyond RT-PCR testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Global Healthcare, Inc. was formed to seek to expand the Company&rsquo;s SARS-CoV-2 (COVID-19) testing into other countries and to pursue
additional healthcare-related initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ProPhase
Labs has decades of experience researching, developing, manufacturing, distributing, marketing, and selling OTC consumer healthcare products
and dietary supplements, including dietary supplements under the TK Supplements<SUP>&reg;</SUP> brand. ProPhase actively pursues strategic
investments and acquisition opportunities for other companies, technologies, and products. For more information, visit <U>www.ProPhaseLabs.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward
Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #1D2228">Except
for the historical information contained herein, this document contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements regarding our strategy, plans and objectives, including our plans to integrate
Nebula&rsquo;s whole genome sequencing services with our already established CLIA-certified laboratories, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #293849; background-color: white">our
ability to make </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">personalized medicine <FONT STYLE="color: #293849; background-color: white">genome
sequencing more financially accessible, our ability to offer significantly faster turnaround times for DNA testing, our ability to leverage
our retail relationships to promote our genome sequencing services, our ability to develop and commercialize accessory tests that complement
our genome sequencing services, our expectations regarding the duration of the COVID-19 pandemic and potential surges (including as a
result of emerging variants), our ability to grow diagnostic testing revenues, and our projections for the remainder of the year with
respect to both diagnostic testing and genomic sequencing services</FONT><FONT STYLE="color: #1D2228">, including our ability to improve
on Nebula&rsquo;s net pre-tax margins and 12-month revenue projections. Management believes that these forward-looking statements are
reasonable as and when made. However, such forward-looking statements involve known and unknown risks, uncertainties, and other factors
that may cause actual results to differ materially from those projected in the forward-looking statements. These risks and uncertainties
include but are not limited to the scale, scope and duration of the COVID-19 pandemic, consumer demand for our lab processing services,
the competitive environment, challenges relating to entering into new business lines, the failure to obtain and maintain certain regulatory
approvals, our ability to continue to ramp up our labs&rsquo; testing capacity and execute on our business plan, and the risk factors
listed from time to time in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and any other SEC filings.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
Relations Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jules
Abraham</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
of Public Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORE
IR</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">917-885-7378</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>julesa@coreir.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc. and Subsidiaries Condensed Consolidated Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands, except share and per share amounts)</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(Unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0pt">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">17,677</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">6,816</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Marketable debt securities, available for sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,639</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Marketable equity securities, available for sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">479</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,644</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,155</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Inventory, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,039</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">428</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,238</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">58,492</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,887</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,914</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,578</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Secured promissory note receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prepaid expenses, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">460</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,084</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Right-of-use asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,564</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,731</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Intangible asset, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,017</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,234</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">901</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">901</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">248</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">240</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">76,323</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">31,405</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,771</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued advertising and other allowances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">463</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">635</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">329</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,211</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,731</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,174</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,294</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred revenue, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">162</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Unsecured convertible promissory notes, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,991</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease liabilities, net of current portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,301</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,402</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,416</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,555</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,590</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,849</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">COMMITMENTS AND CONTINGENCIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Preferred stock authorized 1,000,000, $.0005 par value, no shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Common stock authorized 50,000,000, $.0005 par value, issued 31,806,275 and 28,256,275 shares, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,674</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,969</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,631</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Treasury stock, at cost, 16,652,022 and 16,652,022 shares, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,490</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,490</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(89</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(11</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">47,733</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,556</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">76,323</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">31,405</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc. and Subsidiaries Condensed Consolidated Statements of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(in
thousands, except share amounts)(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the three months ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the six months ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Revenues, net</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">9,142</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">3,623</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">24,413</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">5,511</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,676</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,344</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,020</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gross profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,466</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,279</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,393</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,694</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Diagnostic expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">830</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,639</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">General and administration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,993</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,155</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,775</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,323</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Research and development</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">93</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">208</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">124</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,916</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,220</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,622</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,447</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income (loss) from operations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,450</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">59</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(229</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(753</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">301</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(323</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(574</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Change in fair value of investment securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">164</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">164</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income (loss)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,395</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">70</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(338</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(739</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive loss:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Unrealized gain (loss) on marketable debt securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(67</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(78</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total comprehensive income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,462</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">65</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(416</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(733</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Earnings (loss) per share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.06</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.02</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.06</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted average common shares outstanding:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,154</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,592</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,860</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,587</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,154</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,618</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,860</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,587</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ProPhase
Labs, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in
thousands) (unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the six months ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from operating activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(338</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(739</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Realized loss on marketable debt securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Amortization of debt discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Amortization on right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Lower of cost or net realizable value inventory adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Stock-based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,504</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">396</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Change in fair value of investment securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(164</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Non-cash interest income on secured promissory note receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(315</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,466</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Escrow receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,812</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,130</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(620</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Prepaid and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">91</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Accounts payable and accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Other liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,190</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash (used in) provided by operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,450</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,657</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">Cash flows from investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Issuance of secured promissory note receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Purchase of marketable securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,841</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,436</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from sale of marketable debt securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,029</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Capital expenditures</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,237</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(147</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(21,778</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,554</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from issuance of common stock from public offering, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Proceeds from issuance of common stock and warrants from private offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Payment of dividends</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,546</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,089</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,861</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,103</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents, at the beginning of the period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,816</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">434</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, at the end of the period</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,677</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,537</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosures:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Cash paid for income taxes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Interest payment on the promissory notes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">500</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net unrealized gain (loss), investments in marketable debt securities</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(78</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" ": IP# 2(  A$! Q$!_\0
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MZ49H CXSBOAO_@IOXD\9>$?BKH5]X:\5:IIZW&CL&6QOI8@Q60\D(PYYK[D
MR<D5\0_\%8[4)XG\)W8'WK.X7_QY37Y;XORK4^"*U2E)Q:E%W3L]TNAXV?<T
M<MG)=+?FCY_\!?$OXW>,/%VF>#[?XS>(X3J5]';K,VL3L$+,!G[^3C/K7U0_
M[ W[0%XN^3]K77#GMYUS_P#'J^3?V=XO.^._A*+&=VO6_P#Z&*_6B#F-1[5^
M8>#^0X7BG+<15S*<YN,DHVJ35DU=[-'B</X:&.HSE7;=FK:OMZGQS>_\$W_C
M/<JQE_:8OYF_Z;-<8/\ Y$-<KXE_80_; \'6S7O@KXI3ZD4Y$-GKD]O*WTWD
M+^&[\Z^\57)R*3RSVK]7Q7A;PW6IM4Y5(/NJDK_BVOP/=J9+@I1LKKT;_4_,
M>7]H;]KWX"Z__87B7Q5K%O<0M\UIK*^:'_%ADCW!KZ!_9R_X*3Z7XNU:W\'?
M&33H=,NKAECAU2!CY#L>BN#RASWY'TKU3]M#X&:#\7O@OJK3:>G]K:7;M=:;
M>*H\Q'3YBN?[K $$=._4"OS&"G=AE^[^G-?BO$68<6^%.?TX4\5*M0FKI3;:
M:3U3\UW1\YC*V.R/%)1FY0>J3[=O)G[,6L\-Q L\#JZ-@JRGK7CG[?UN+C]E
M_P 0K_=CA;\I%K"_X)S?%;5/B)\#5TC6[IKBZT&Y^R&21MS&/&4R?8''T%=-
M^W3$9OV8_$W./]%0_P#CZU^[9CFU'B#P_JXZDM*E*3MVT=U\F?45:T<5E4JD
M=G%_D?F7I2&34K6/'WKA!_X\*_8+PE!]E\-Z?:K_ ,L[.-?R4"OR!T#G6['G
M_EZC_P#0A7[#:  ND6X_Z=U_E7Y)]'N-Y8Z7^#]3Y_A3_EZ_3]2Y13=S9QFA
MFQTK^F3[(=13=_RYI0V10 M%%% !137)'0T*^>": '44TL<X% 8YP: '44T.
M<\T*Q+8S0 ZBBD9L"@!:*892HYI2Y/2@!U%-$F.#3MW&: "B@$'I0"#T- !1
M2$\<4TENI- #Z*,CUIC.>YH ?11F@'C)H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@!IZTTF@M@;:Q=0\;^&]-\86/@>\U*--2U*UFN+.V9OFD
MCB*!\?3>*J$92T2,Y5*=/6;MT^;-[(]:*C5@#4F>]2:!1110 4444 -]:^/?
M^"LL8_X1CPE+C_F(S+_XY7V$/NU\@_\ !63'_"(>%,C_ )B<O_HNOSGQ6Y?]
M1<7?LOS1Y.>?\BV?R_-'R;\#8A<?&7PO$?XM>M1_Y$6OUNMB#"O^[7Y+_L\(
M9/CMX0C_ +WB"U'_ )$%?K-#Q&N#VK\]^CZO^$G%/^\OR/)X4_W>IZK\B:C@
M4TECSFF/(%&6-?T-S1/K"EXIN8+7PU?7-P^V-+.0M]-IK\>=5FBN=3NKJ'Y5
MDN)&C]@6)K[^_;X_:ET/X=^ +SX8>%]2277M8@,+K%(";2%AAV;T.W('?OVK
MX*\(^$_$'C?Q%:^%O"^F375]>2K'##&NX\]S_CTK^4?'#.,/G6=8;+<'[\Z:
M=[:^])JRTZZ'P_$V(CB,1"C3U:O][Z'V+_P2:TFZ31O%FM.&\F2ZMXD]R%8_
MUKZE\>?$GP5\,M-CUCQOK]OIMK-.(8YKI]JER"0N?P-<O^RO\$+;X"_"+3_!
MS,LE\W[_ %29?XYVY8#V'"CV&>]>>_\ !3NP%U^SB;G;G[/K-L_YEE_K7[!E
M-/&\#^&\9N*=2E3<FGW>K3MVN?08>-3+LG5UK&-[?C8]&G_:L_9_MH?/F^*F
MDA?:[7_&NWAUC3YM,36HKQ/LLD(E29FPNPC(;/TK\?O#=E'J/B33].D Q/?1
M1DG_ &G KZ?_ &EOVB/B/\>/%B_ ']GVUNI-/LU\JZDT_.ZY9?E8%ATC7]3[
M=?C>'?&:MF&!KU\507.FHTX1NW-N_P""MN>?@^()5J,I3CJK))7NVSZ,^(7[
M='[/'P[OY-,OO&BW=Q&V'AT^)IL'TRH(S6M\"/VI?AI^T-/?6G@.6\:33U5[
MI;BU:/:&R!R1@YP>E?%MI_P3@_:/O+ 7\FF64;LN[R9+L;__ -=?07_!.?X)
M>/\ X-P>+;+XA>&Y+&XFO+=86?E9557)*D=1EJ]3AGB[Q S7B6E1Q^$]C0E?
M7E?1-K7ST-L'CLTK8Y1JT^6#ONO+N?3T3'.UC4-S>6]G"UQ=7"Q1K]YW; KE
M/C-\8_"/P2\&W'C7QC?".*/B&%?OS/V11W)K\^OC=^U[\9/VA_$2Z'H]Y=:?
MIMQ/Y5CH]@Y#2Y.%WD<L3Z=!^M?6\8^(64\(VHR3J5Y?#".^NS?;\SNS#-L/
M@?=>LGLD?=?CG]K7X!_#R5H/$7Q'L!,O6&"3S&'X+FN%O?\ @I7^SK:2^5;W
MVI7(_O1:?)_A7#?LZ_\ !-KPY:Z=;^*/CB\E]?3+O_LE)"L4?^^PY8^O-?0F
MD_LW? [1K=;;3OAAHZHO W6:LWYD$_K7GX#$>)&<T57Y:>'C+51E>4K>?0SH
MSS;$14WRP3V6K?S//-(_X*.?LTZE+Y-QX@O+/<<9N-/D 'XXKTOP/\>?A+\1
ME4^#?'>GWFX?+''<#<?P)S6-XN_9,_9_\9V;V>J_#/3DW+\LMK%Y+J?4%<<U
M\?\ [4W[$GB;]GM6^)7PKU:\N=&A;=*58BXLP3C)*XR,X&>/>N;-LZX_X7HO
M%8BC3Q%&/Q<EU)+O;7\",1B,UP<>><5.*WM=,_0N)P4W;O\ Z].R IR:^!?V
M5_\ @H9XG\'WMOX,^,UW)J&ER,$AU5QF:W[#?_>7WZCWK[LT76-.U[2[?5M*
MNXY[6ZB62&:)MRNI&00?<5]5PEQID_&&#]KA)6DOB@]T_3MYG;@<PP^84^:F
M_5=47<?+G-?%W_!66/\ ?>$K@C_GY7_T&OM \<5\9_\ !68_+X1_ZZ7'\EKP
M_%Q+_4/$I^7YHYL\_P"174^7YH^;_P!EZ+S?VA/""?\ 4:A_G7ZN6Y'DCFOR
MH_9. ?\ :,\(C/\ S%HS7ZJPC]TIKXOP C;(<0_[Z_(\SA;_ '67J349 ZFF
M;R>0::SJ!N9J_H"]M6?5&)\3KZUT_P"'^M7EZX$<>F3LY;ICRVK\@;AP\TA!
MX9B>OO7WG_P4(_:DT/PMX'NO@_X3U%)M9U9/*O6AD!^RP?Q9]&897'N37P_X
M&\#^)?B)XFM?"/A'3)+J\O)0D<<:_=S_ !'T'J>PS7\D^-N:T<^XAPV6X)\\
MJ::?+K[S:TT[:'PO$E:.*Q4*-/5KMW?0^T_^"4.E74'PZ\2:M,N(KK6$6'WV
MQC/\Z]9_;CP/V8_% _Z<U_\ 0UKH/V;?@[8? [X4Z7X#MV62:WBWWLX'^MF;
MEF^F>!["N>_;GQ_PS'XHP?\ ES7_ -#6OVC"Y35R+PQ>#J_%&B^;R;3;7RO8
M^BIX>6%R?V<MU%_CJ?F9H'.O6(S_ ,O4?_H0K]@])DCBT:!I7"C[.AW$^U?C
MSHLL<&KVL\K[56ZC+-Z ,*^Q?&'QI^,W[77B63X2?LZO)I_A^P18]4UX$IYA
MQ@@-V7K@#D^P'/XGX-\18?(:.,7*ZE6;BH0CJY/7\.[Z'SO#N*CA8U%:\FU9
M+=GT'\1/VL/@3\,)&M?%/C^S6X7[UK;OYLG_ 'RN37GTW_!3']G.&X\A;W4I
M%SCS%T]\?J,URWA/_@ECX*\@7?CWX@:E?73\S?955%W=^6R3]3S5WQ'_ ,$L
M?A+=6C)X<\5:M9S;?DDFD65?H1@?SK]6QF8>+F(BZV&PU.FND;INWGKN>W4J
MY]+WH0BET5[OYGH?@?\ ;J_9Q\:726-KX]CM9I,!8[Z-H<GTRP KUK3=6T[6
M;&/4-,O8YX9!E)87#*P^M?EC^T1^S9XW_9U\1QZ3XD"SV=T3]AU"%3LE ZCG
MH1Z5V'[&O[67BOX->-[/POXBUB6X\-ZA,L,UO<2;A:,2 )$ST /4=,>XKYW(
M_%[,\+G7]E\0T%3E?E<E=6;VNNWFCDPO$%:GB/8XN%GM?S]#]+,CUHR.N:KV
MT\5S D\+;E=05;U!J1B2N :_H.-2,X<T3ZH;/(D?[QW 5>237$^//VAO@[\-
MHV/BWQ[IUK(O_+,W +'\,]:^>_VP/B#^T5XW^/$7[.GP=O)+6UDT^&>XFM?E
M?#EMQ=_X5 ';!]ZU/AI_P3)\!VT*:M\7O$M]KFH-\TT:3%(]WIGJ?KQ7YYC.
M*N(,?F%7!9+A>;V;Y74F[0OU2ZL\JICL35K2IX>'PZ.3T2?ZG2:K_P %)_V;
M=/F\JVU>^NO]J'3Y-OZBKGAS_@HI^S5K\ZV\OBF:Q9CA6O+21%'U)&!6I_PP
M;^RX;?[./A= .V[[7-N^OWZ\<_:!_P""9NA1Z/<^(_@G?3Q7,,;2?V5=/N27
M'.%;J#]<YKP\RQ/BQE=&6)2I54E=QBG>WSW.:M//*,.=*,K=%<^K?"7CKPEX
M[T]=5\)>(;6^MVY\RWE#?R-;2;=_#5^2?PN^,'Q(^ 7C0:MX7U.:UFM;G9>:
M?(Q\N7!^9'3_ "0:_3GX$?%S1/C?\.-.^(.AC8MW%_I$.[F&4'YD/T.?\FO3
MX!\1L+QESX:K#V>(AK*+V:VNO1[IFV5YO3S"\&N6:W1VV<KFFN?4TO'=J^?_
M -N/]JF?X!>%(M!\*E&\0:LK+:LW(MH\8,I'<CL/6OML\SK!</Y74QV+=H15
MWW\DO-GI8C$4L+1=2H[)'J'C_P".'PM^&$#3>./&MC8G_GG),-Q^@Z_I7E>J
M_P#!2K]F[3IS%;:O?76WJT-@^/U%?+?[+O[._BO]K[QS?>)O'GB.\?3;&53J
M%](^Z2>1LGRU)Z<>V "..E?:'A_]C#]G+P]IJZ;:?#*QEVJ TEQND=CZDL:_
M-LIXBXZXPHO&9;3IT:#^%SNY2MU270\?#XK,L?'VE%*,>C=W<YWPW_P40_9K
M\13+!/XKEL68XS>6KHO_ 'UC%>M>#_B3X(\=P+<>#_%%EJ"LN?\ 19U:O!/C
M_P#\$ZOA=XOT"XU7X8Z9_8NK11LT,<+DPSM_=8$G'L01CN*Y7_@F5\%=3T&X
M\1?$#Q-93V]U:WC:9#;RY7:RX:0X_$#/M79EN>\>8/B.EEF98>$X33?M(W2L
MEK_PS-*.)S.GC(T:T4T^JOT/L2/Y>,T9 YS3.&')KA_CS\<O"'P"\#S^+O%,
M_P#L6MJK#?/)CA5'X?05^E8['87+L+/$8B2C"*;;>R2/7J5(48.<W9+<[#4M
M7T_2;5KW4KV.WB3EI)I H'YUY?XS_;9_9Q\%3M::E\1+::93AHK,&8@^^W-?
M!?QD_:8^,7[1GBA;2\U&XBM;BX\JPT2QD(3DX52!]]C[_ABOI;]FO_@G!X4T
MK2K?Q9\;H7U#4)D#KI*R%88<\X;'+-^( ]^WX[A/$;/.+<RGA>'<,O9QWJ3O
M9>=EWZ(\"GFV(QU9T\)'1;R>WX'72?\ !3']GA)?*AFU21?[ZZ;)C^5;7AK_
M (*!_LS^(IEMV\:FRDD.%^W6KQKGZD8KN[+]G?X)V%NMI;?#+15CQ@C[ A_F
M*X'XQ_L%? WXF:3,-(\.QZ'J6TF"\T]=H#8XW)T(_+ZU]+B*/B5A:+K4ZE*J
MUKRV:OY)G9)9O3CS*49>5FOQ/6_"WCOPIXULUO\ PMK]K?0MR'MY@PK9!RN*
M_*S7(_C3^QY\59-"LM>N+&\LY!)&\+'R;J,G@[>C*?IGZ$<?<_[(G[6.B?M&
M>'&L[Y4L_$&GHIO['=]\=I$]5SU]#U[5R\(>)6%S[,)9;CJ;H8J-TXO9M;V\
MS/ 9Q'%5G1JKEFNA[?FBFH>U.K]3/:"BBB@ HHHH **** "BBB@ HHHH ***
M* "@G R: 0>E-D?:.#0!7NKF&VA>XFD C1-SLW0"OR9_:D_;RUN[_;JL?B_X
M-OVDT?P7J!LM/C5_ENH Q2=OHX)Y] *^L?\ @J+^V#;_  C^'DOP?\$ZFO\
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M&K?+),!^\D(^N0/8>]=%_P $S_A%8^./BS>>/=8MUDM?#MNIME=>/M$AX/\
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M4$>]3U4TQ'CL8(Y!\RQ*&]CBK=?U_0E*5&+EV1]Y'X0HHHK8H**** "BBB@
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M9_[ZQ7ZRP_ZI.:^,^C]*^2XJ/::?WK_@'G<*_P"ZS7G^A+30@[TZBOZ#/J@
M Z"BBB@!I)S7D/[<[*O[,'BC=_SZ+_Z&M>O+PWX5XO\ M^7(M?V7O$1W?>CB
M7_R(M?,\824.%\9)_P#/N7Y,Y,?_ +G4_P +/S5T8XU>S(/_ "\1G_QX5^PG
MAYE;1+/_ *]4_P#017X\:>X2_MW!^[*I_45^O_@BY6X\)Z;<Y_UEE"WYH*_"
M?H]R][&Q?]S]3YGA1_Q5Z?J;%!&1BB@MBOZ</L3F?C!)Y7PO\0RC^'1KD_\
MD)J_(A>5Q7ZU_'B\6S^"_BJ[+?ZKP_>.?;$#FOR37B/%?RYX_P KYE@8^3_-
M'Q?%3_?4O1_H?J[^S!;?9?V??"$8_P"@#;'\XE-:_P 5OB5H/PF\!:CX_P#$
MDH6UT^WWE1U=N@4>Y. *H_LYO')\"/")0\?\(_:#_P @K7C?_!4274E^ %I'
M:,RP2:] +K:>"NR0C/MN _$5^SXS-*N1\ _7*2NZ=&+2\^56_'?R/I*E:6&R
MWVD5?EBK?<?)?QR_:S^+7QOUF9K_ %ZXLM.9\6^EV<A50OHV/O'%>\?LO_\
M!.C1=:\/VOCGXTR3-)=QK+#I,+;1&IZ;SW)'.*^1?"]S8V'B?3KW4XQ):PW\
M+W"'^*,.N[],U^O^AW5CJ&D6][ITJ/;RP(\4B-\K+C@CVQ7XCX3Y;A^.,TQ.
M/SF;K3A:T9-VUOK;LK6/F<AHQS+$3K8A\S5M'MKY'+^$_P!G3X*>"X53P_\
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M &GLU)IWM?1.YGF&#^O89TKVO;\S\H?A?I7B'1OB9X>U"YT2\C6+6[4[GM7
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M*_+=?#7B5DR/#]]M_O?9'_PK]AK[3K;5;9K&^M5FAD&)(Y%RK<YP0:IKX/\
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MOV?$7]XS8O\ @IK\?XQA[72V_P"W>KEI_P %1?C5%_Q\>'])D^L;#^1IS_\
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M(_7\2H1]X4 QU^5?A_\ :Z_:+\-LK6'Q6U1E3_EG=2>8OY-FN_\ #'_!2_\
M:#T8K_:RZ7J2+U^T6NS]4(KZ#!^.G#%;_>:4Z?JK_D=-/B;!2^-./R/T74@K
MBFL,&OBOPS_P5?O 5C\4_#1<'[\EG<_T(KT+PQ_P4Y^!.K[5UNVU+3VZ'S(
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MD\3>%4.LZQ/&F6G\P9N%]<(N,>T=?J7"^2\/X?+:57.87EBI<E/6W*DK<_\
MX%9'Y/Q3GF?8C,JE/*)6CAH\U3KS.Z]W[KGZ$Z;J%IJ]C#J-A*LD-Q&KQ2*W
M#*1U%3L,#=BOE?\ X),_M'#XV?L[0^#=:U'S-:\(%+*Z#M\SP$'R7YZ_*I7Z
MK7U4S#.:_/\ .<LK9/FE7!U5K"37RZ/YK4_0LDS.GG&5TL73^W%-^O5?)GQ/
M^V7_ ,%+/BG^SK^T.?@KX&^'&G:OYEM;M;M<22"2224<)P<?2LT?MW_\%$G&
MY?V.%V_[LO\ \57B'_!1_6M-\.?\%)])U[6;I;>TLVTN>XF?HD:N"Q/T%?<<
M/_!1G]B];=5;XV:7]W_GG+_\17Z1CLKP>6Y)@*V'R_VTJU/FD_>=G\C\QP>:
M8S,LZQM+$9@Z*ISM%::JWF?/>J?\%3_VF_A3-'?_ !P_92N+'2S(!)<0&1,#
M_>;*YKZZ_9U_:*^'7[3/P[A^(?PYU$RV[/Y5Q;R<26TP )C<=B,CZYKYA_;=
M_P""AO[*_C#X%:_\,? VJQ^*-8US3Y+.QAAM3LCD<;1(68#&"01BM[_@D+^S
MA\0?@7\(-:UWXA0FUF\3WT-Q:Z;Y@;R840@,V. S;NG8**\W.,HR]\+_ %^K
MAGAJRFE%7=JBZM)ZJQZF1YQF$>*%E]/$K$T7%N3TO!]%=;W/K#Q'KVC^&-!N
MO$>O7R6]E8V[3W5Q(V%C11EF/MBOB'Q-_P %2?C#\7O'-YX(_8Z^!\FN0V<F
MQM6NE)5^>'P,!%/;)S_*OIK]M7P)XK^)G[+GC3P1X'#-JFH:-(EG$C8,K AO
M+_X$ 5_&O@O_ ()P?MI?#+]CS1-=^$?QQ\)WVDW\VL&=K[['^\'R*GER*<,,
M%21UX-8\)Y/@\3DV(QRH^WK0E%1IM]'O)I:OT.CB[.,9ALXP^"]LZ%&:;E42
MOJMHI[(]<N/VA/\ @K-X<MVUG5OV?]-N;>,;I(850L1] V<UW'[*'_!3SP[\
M9_'W_"E_B[X-F\)^+&D\J&WN&/E3R_W.0"C>QSFO2_!'[?G[(WCXI!HWQFTF
M.63_ )8WTA@;_P ? 'ZUQ_Q,_83^ _[1?QLTO]I+PYX^FM=0L7@D\S0+B%H9
MWB?<'8@'DCY3@]!1*ME=:G4HYK@?J[Y7RSA&2M+HFG=-,FG1S.A5IULJQ_UA
M<RYH3DM8O>S[H^F4.1G-/+@'%1P_NU5,YP,9J4J#R17YZ?I,;VU"BBB@8449
M'K1F@ HH) ZFH]XZ;J )**C+$+C-4M;\3:#X=LWU'7M9MK.&,9>:YG6-5^I8
M@"L:M:E1CS5))+S=A.2CJR_N;TH/!^]7A/Q$_P""@?[//@0206?B5M8N8_E\
MK38]ZY_W^%_(FO"?B'_P51\9WXDM_AWX*MK)6R%N-0D,C#WVC S]<U\/F_B5
MP?E%XU,0I27V8>\_PT/-Q&;X'#[SOZ:GW1.,HP!ZBORSUJ.Y^"W[0C&5#&=!
M\3;UX_@67(/_ 'S7VU^PM^T'XA^/7PXN9_&\WF:UI=XR74WDB-98V.Y& ''3
M*\?W?>O$_P#@I1\!+W2?$D?QJT&P9K*^40ZMY:_ZF;&%<X[,!MSV./6OUSPU
MX@P.:4U4@[4\1'2^EGV?GJSY;C"E+&972QM!7Y'?Y.WZH^TM!UFR\0Z':ZWI
MLPDM[J!)8V4YRK+D5\3_ /!8KX<W<EAX9^*=K;,T,<DFGW<BK]PM\\>?8X<?
M7'K70?\ !/7]K6PFTR'X$>/]46&XMSMT"ZF; DCSGR2?4<[?;CL!7TO\:?A5
MX=^-WPTU;X<>)8 ]OJ-N41MO,3]4D7T(."/I79AO;<*\10G56D7]\7V^3-,=
M[#C+A6=.D_>:^Z2UL_NL?B)K&<$YKD=8Z,,U[%^TI\ _'G[._CFX\%^-M+EC
M"L38WWEGRKJ/^^A[^X[5XYK.0&(%?TME>*HXW#QJTG=/5-=NA_&N?X+$8'$3
MHUXN,HNS3_,YJ[^\WU_K6?<UH7#$NP)[UGW-?0'Q]/XBA<D]JSI(Y991;1#+
M-)M '<UH73;1G-?1W_!++]CS4?VI?VD-/UC6]*=O"OA6YCO]8E9?DFD4YB@]
M#N8 D?W0?6O+SC,:.59;4Q59V44W_7J?5\.Y5B,YS2EA**NY-?G^B/V&_9#\
M!7/PR_9G\$^!KV'RYM/\.VL=Q&1R'\L%@?Q-8_B7]B'X#>,?&>H>.O$WAR2Z
MOM2N3-<-)<-M+>PSTP,5Z_!$(85A1<*J@  =*D*D<XK^*,ZR_+\^J.6-I1G>
M3DE)72;9_?.'P%&E@J>'DDU!)*_DK'EVD_L:?LXZ2V8/A=IS?]=HM_\ .NBT
MWX$_![1AC3OASI,>W_GG8I_A78+GKF@CLM<%'A_(Z'\+#0C_ -NHWCAL/#X8
M)?)&3;^#?"EK@6OANS3']VW48_2KD>F6$(Q#91KCLL8JUL(I5R.M>A#!X2GI
M&G%?)(U4(1V7X$7DQ+P(UIX7CA!3MB^E(0P^[6ZA&.R2*$$9STI=@W;L4ZBK
M CVJ#AEI21C 6GT4 -^3IMIO7@"I** &;&]*505&33J* &[U]*!'SDT[&>HH
MH :VU1MVT>4M.HH :8AV%($(.=E/HH C:.,]1^E,:VMVZQK_ ,"6I0JGF@KW
M45#ITY;I/U2 I2Z'I$X_TC2K>3/]Z$&J%_\ #GP)J*[;[PAITGKOLT_PK<PW
MI00Q_AKFG@<'4TE3B_DG^A/)![HX/5/V:/@3K(8WWPNT=F;^+[&H(_'%<SJW
M["W[-&J;O,^'=O"3S^Y9EQ^1KV(;AT6@KFO.K<,\/XC^)A8/_MU&,L)A9_%!
M?<CYSUC_ ()G?L\:DWF6<.HVC?P^3>'^M<KK/_!*;P!<#=HGQ U*W/\ ")41
MQ_+/ZU]:X _BI?*QTKPL5X;<%8OX\''Y77Y'+/*<OJ;TU\M#X5U[_@E)XWMU
M9_#7Q+LISU5+BS9/U#'^5<[_ ,,-_MF?#R47/A76(VP<K_9NL.I_)@*_0PA1
MU%'##&VO#J^#_"CES8;VE)_W9M(YY9#@?L7CZ,^!=+\9?\%&?A>%CO=$U6^C
MB_AGA6Y!_(FNHT'_ (*-?&7PM*MG\3O@C<.L?^LE@ADA;Z\@C^5?:#1(PVM&
M,=QBJ=YX=T.^!CO-)MY%;JLD(.?TK3#\!Y[EK_V#-:B7::4E^/0<<LQ-'^%7
ME\]3PGP/_P %'OV??%++;:Q>WNBW'\2ZA:_*#_O+G^0KUWPO\7?AMXUB6;PM
MXVTV^W?=$%TI;\LYK-\2?L\?!7Q:#_;GPVTFX9OXGLDS_*N"UC_@GM^S[>3M
M?:#I^HZ/<[LK-IFI2Q[?^ YV_I7L4/\ 7K!:5/9UTNJO!_JCIBLRIZ2Y9>>S
M/=$D5AD/3L9X#5X3I'[-7QL^'H_XMM^T9JC6Z_ZNRUZW2[3']W) *CZ8-=9H
MNO\ [1&@*(?%?A#1]65?O7&DW;0L?^ /D?K7M8;.,5MBL-*#_P# E]Z.B%:3
M^.+7X_D>E*".<TZN>T;QHVIE8M0T'4+&8\>7<6Y90?\ >3*_F170(<KUKW*=
M2-2/-%W-HRYA:***T*"BBB@ '2J7B(YT&\Q_S[/_ .@FKHZ54UJ"6YTBYMX5
MRTD#*H]\&JI_Q%ZHQQ%W1DEV9^8__!(%A_PVQXT'_4(O/_2M*_4#GI7YA_!O
M]CS_ (*(?LV?%W6_B9\)_!NAFXU(S0;KV\5U,+2[\XQUX%>PCQ;_ ,%C_P#H
M3_"/_?25^J<:9=A\^SA8O"XNCRN$%K.SNHI/2Q^4<&YGB.'\IEA,3A:KDIR>
MD;JS=T?;0/-8_CCQ?HO@+PIJ/C/Q%?K;V.F6,ES=32' 6-%+$_7BOEWX3>)/
M^"J%W\1M'M?BCX8\+P^'VOD&KR6K+YBP_P 6WWKIO^"E7PU_:)^-7P=M_A/\
M"-&BFCU2Z!UVXFO!'^X3D1#/4,V"?9<=Z^+IY'3IYM1PU?$4^6;7-*,KJ*OK
M=][=#[>IGU:MD];$T*$U.*TC*-FWTLCX)\*W?[2_[6G[4>K?M0?"?X:_\)%)
MI&K+);0WK*((%^;R$^8@'"KG Z'D]J^F]5^+/_!676=*GT34OV>]%FM;F!H9
MHF:(AU(P0?GZ'D5]"_L*?LT)^R_\ =)\":A;QC6)O]*UR6/G?</U&>X484?2
MO:&48P *^HX@XTPM?,%1H8:G.E1]RFY)M\L>NC6[U/DLAX'QD,"ZV(Q-2%2M
M>4TFMY='Z;'Y _LI^*?B=^P7^V5INF_%SP_)H-KKVVWU:Q>0&/[/,Q\N0$$@
M[&QWXP?4U^O5K/%=P1W$3[D==RL#U!KY+_X*C_L1>*OVG] T'QA\*M.A?Q-H
ML[1,DD@C6>U?D@L1U5@"/]YO6O:OV0[+XR:1\!M#\/?'73%M_$.E6XL[AH[@
M2BX2/"QRY'<KC/N#6'&.8X#B3+\-FL91C7MR5(+>Z^&279K]$=/!N7YAPWF6
M(RF<92HW4H3Z:[IOO<_/?_@H[H^G>(/^"DVDZ)JUHLUK=RZ5%<0MT=&8 @_@
M:^Z+?_@GE^R \2.WP5TGE<_ZNOF?]N_]B7]J+XH_M<1?&[X/>&K&ZM;.&SDL
MY;J\"XFB.<%3VXKK(_%'_!8R- B^#O!_RC'WDKW<RQ%7,<ARZG@,="FZ=.TT
MZG*[W5KH^?RW#T<MSW'SQ^!E552I>+4.96MT/1/BC_P3 _9(\7>&;J#3O ,.
MBW7DL8;^PD*-$W4-UQV%?.__  2.^-WQ*L/CWX@_9RU;Q/<:QH-K#</:-<2%
MQ \4FS*DY(5AVSBNL\6_#_\ X*]_&[2Y/!OB3Q)H/AS3;Q3'=26+(CE#U&Y5
M+CC/ (SWKVK]A+]@?PQ^R%I5YK%YJIU?Q-JR*NH:FR;5C0<^7&/3=R2>6XSP
M !Q5,PI9?PUB<+F6+CB:E1+V<4W/D=]9<SVTZ(]"AE];,.)L-BLNPLL/3A?G
M;7+S*VD;+?7J>B?M(_M(^ _V7? *?$?XDVVH2::]\EKG3;82NKL&(+ L,+\N
M,Y[USOA7PI^RQ^VO\.M/^*__  KG3=5L=2C9H9+^Q19T(8J0V"<-D=,FNV^/
M'P7\(_M ?"[5/A5XWM#)8ZG!M9E^]#(#E)%/9E(!%?#O@O\ 9?\ ^"C'[#6J
M7FG_ +/>J6/BOPS-<&1=+N)%^;T.QR-K8ZE6'X@"OG<CP>78S+9.CB?8XN,M
M.:7+&4>R?1IGT>?8O,L'F476P_ML)*.J4>:49=[=CW3QQ_P24_9!\6H[:?X1
MN-)D8?+)I]VR;?PS7Q[^U%\(_B?_ ,$N_BIX=\7?"+XL7USI>L-,T-K<RG.8
MC'NBD4'#J1(,' YS^/T(/VG_ /@JG=Q_8(/V3-*BF;CSI)OE7W_UW^-<W:?L
M _M6?M=_%73_ (E?MK>+K6WTS3\>3H.G$<1E@QC4+PF< ,W)/X9K[#(\=F&6
M5I2SK&0J8?E?-!R51RTTMN[WMK<^,SK!X'-*<8Y-@YTZ_,K247!+76_38^YO
MAKXK_P"$Z^'VA^,_(:+^U=)M[SR7ZIYD:OCZC<:WMYJGH^E6FBZ;;Z5I\2QV
M]M"L4,:K@*JC 'Y"KH4'DBOR"LX2J2<-KNWH?LN'C4A1BJF]E?UZBT,P49-%
M-D( R:DU&[@:42 <DURWB[XL>$/!\_\ 9UU=2W>HE<QZ7IL+7%RW_ $!('N<
M#WKA]9\6_M-^.R;/P!X"T_PU:R<+J'B"833*/40QG /U8_2O)QF;8?"^[%.<
MNT5=F-2M&&F[[+4]6U?Q!HFB6;:AK&J6]K"GWI)Y@JC\37B/Q/\ ^"@7P$^'
MK/8:/JTGB"_Y"VNEIN7=[O\ ='X9-4T_8:G\>WZZQ\>_C%K_ (EE#;OL<4_V
M:V7_ &0J<@?0BO2/ O[-7P1^',"CPG\-]+MW7K.;8/*WN6;)/XFOGL16XRS+
M3#0AAX?S2?-+[EHOF<TI9A5T@E%=WJ_N/F;6?VK?VSOC.S67PA^$=UH]I*V(
M[C[.68#U,D@"Y^@K(MOV$OVLOC-=#4?C%\2([16_AN;I[ID'IL&%'X-7W-#:
M6UNBI;0*BC@+&N*F56/&*\B7ARLRESYOC:E9]5?ECZ61S?V2JSOB)REY7LON
M/EGP9_P2Q^%>E;9_&/BC4M4D7EE1A#&?P S^9->L>#?V//V>O Y5M)^&M@\B
M_P#+:ZC\UL_\"SS7J&./E_*G'/:OH,NX'X5RNWL,)"_=J[^]G51RW T?@IK\
MS-TS0=,T:'[+I.G0V\?988PH'Y5#XI\*Z+XR\/7?ACQ)IT=U8WD+1W$,BY!4
M_P"<UK$,30R?(0:^LHQCAK*DN6VR2LE]QU2I4Y0<&E9JUNEC\U_VL?V+/'WP
M*UR;QAX&M[G4?#OF&:WN[7/FV)ZX?'/T8?CBM#X"?\%1?'?PRMH?#/Q;T>3Q
M!I\8"+?1R!;J(=.<C#_0X_WJ_1"ZL[>\@:WNX$DC;[R,H((]#7@GQM_X)Q_L
M^?&.XDU>VTB;0-2ER6NM'VQJY_VHR"I^H /O7Z!@^)LNS#"K"YQ2YDMIK?\
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MGTIXZD4M9QC&/PI($N78:$(& :/+(& :=16@"! IR!2T44 &.<T444 %%%%
M#=GO0$/K3J* &A#GDT;#W-.HH ;LXZT;#V-.HH :J[:=110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
